Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

NCT01792830 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Poor Glycemic Control

Interventions

DRUG: Metformin
DRUG: Glargine insulin
DRUG: Glulisine

Sponsor

Emory University